Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia  by Mohn, Amy R et al.
Cell, Vol. 98, 427±436, August 20, 1999, Copyright 1999 by Cell Press
Mice with Reduced NMDA Receptor Expression
Display Behaviors Related to Schizophrenia
Mice lacking each of the known NMDA receptor sub-
units have been generated (Forrest et al., 1994; Li et al.,
1994; Ikeda et al., 1995; Sakimura et al., 1995; Ebralidze
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and Beverly H. Koller*²§
*Curriculum in Genetics and Molecular Biology
²Department of Medicine et al., 1996; Kutsuwada et al., 1996; Das et al., 1998).
University of North Carolina at Chapel Hill Mice lacking NR1 or NR2B protein die perinatally (For-
Chapel Hill, North Carolina 27599 rest et al., 1994; Li et al., 1994; Kutsuwada et al., 1996).
³Howard Hughes Medical Institute Laboratories As a result, mice deficient in all NMDA receptors cannot
Department of Cell Biology and Medicine be used to study diseases that have been hypothesized
Duke University Medical Center to be associated with NMDA receptor deficiency, such
Durham, North Carolina 27710 as schizophrenia (Javitt and Zukin, 1991; Coyle, 1996;
Carlsson et al., 1997; Goff and Wine, 1997; Tamminga,
1998).
Summary Schizophrenia is characterized by episodic positive
symptoms such as delusions, hallucinations, paranoia,
N-methyl-D-aspartate receptors (NMDARs) represent and psychosis and/or persistent negative symptoms
a subclass of glutamate receptors that play a critical such as flattened affect, impaired attention, social with-
role in neuronal development and physiology. We re- drawal, and cognitive impairments (Ban et al., 1984). A
port here the generation of mice expressing only 5% of major explanatory hypothesis for the pathophysiology
normal levels of the essential NMDAR1 (NR1) subunit. of schizophrenia is the dopamine hypothesis, which
Unlike NR1 null mice, these mice survive to adulthood maintains that dysfunction of the dopamine neurotrans-
and display behavioral abnormalities, including in- mitter system underlies the behavioral abnormalities
creased motor activity and stereotypy and deficits in that accompany schizophrenia. This hypothesis is based
social and sexual interactions. These behavioral alter- on the observation that drugs effective in treating
ations are similar to those observed in pharmacologi- schizophrenia share the common feature of blocking
cally induced animal models of schizophrenia and can dopamine receptors (Anden et al., 1970; Seeman et al.,
be ameliorated by treatment with haloperidol or clo-
1976). In many respects the behavior of patients with
zapine, antipsychotic drugs that antagonize dopamin-
schizophrenia is consistent with elevated levels of dopa-
ergic and serotonergic receptors. These findings sup-
minergic neurotransmission, and some of the symptoms
port a model in which reduced NMDA receptor activity
of schizophrenia can be reproduced by drugs such asresults in schizophrenic-like behavior and reveals how
amphetamine that increase dopaminergic tone (Griffithpharmacological manipulation of monoaminergic path-
et al., 1972; Angrist et al., 1974). However, altered levelsways can affect this phenotype.
of dopamine or dopamine receptors have not generally
been observed upon postmortem examination of the
brains of schizophrenic patients (Knable et al., 1994;Introduction
Lahti et al., 1996; Carlsson et al., 1997).
An alternate explanation for the etiology of schizo-NMDA receptors, together with AMPA and kainate re-
phrenia is the glutamate dysfunction hypothesis. Thisceptors, comprise the known ionotropic glutamate re-
hypothesis originated from the observation that phency-ceptors (Nakanishi et al, 1998). NMDA receptors have
clidine (PCP) intoxication closely mimics schizophreniagenerated considerable interest due to their unique
(Luby et al., 1959). At serum levels that produce schizo-pharmacological and electrophysiological properties
phrenic symptoms, PCP acts as a noncompetitive an-and their role in synapse refinement, neuronal plasticity,
tagonist of NMDA receptors (Javitt and Zukin, 1991).and excitotoxicity (Nakanishi et al., 1998). These recep-
Ketamine and MK-801, two additional noncompetitivetors require concurrent membrane depolarization and
antagonists of NMDA receptors, also produce schizo-glutamate binding for activation. Under these condi-
phrenic symptoms (Ellison, 1995; Malhotra et al., 1997;tions, Ca21 influx through the NMDA receptor channel
Abi-Saab et al., 1998) and exacerbate symptoms in pa-provides a second messenger system linking synaptic
tients with schizophrenia (Javitt and Zukin, 1991). Theseactivity to long-term changes in synaptic efficacy (Na-
findings led to the use of PCP- and MK-801-treatedkanishi et al., 1998). Functional NMDA receptors are
animals as models for schizophrenia (Carlsson andcomposed of a common NR1 subunit and one of four
Carlsson, 1990; Corbett et al., 1993, 1995).NR2 subunits (NR2A±NR2D) combined in an undeter-
The glutamate dysfunction hypothesis is not inconsis-mined ratio to make the heteromeric receptor complex
tent with an important role for dopamine in the patho-(Kutsuwada et al., 1992; Monyer et al., 1992). An inhibi-
tory NR3 subunit may also be present in the receptor genesis of this disease or with the current therapeutic
complex, particularly during development (Das et al., approach for schizophrenia, which relies on drugs that
1998). act through dopamine receptor blockade or the com-
bined antagonism of dopamine and serotonin receptors
(Meltzer, 1991). Glutamate and dopamine have been§ To whom correspondence should be addressed (e-mail: treawouns
@aol.com). reported to exhibit reciprocal actions at subcortical
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structures (Nieollon et al., 1983), and therefore dopa-
mine receptor blockade may act to balance gluta-
matergic insufficiency (Carlsson et al., 1997).
We describe here the production of a genetically al-
tered mouse line that expresses 5%±10% of the normal
level of Nr1. While these mice are deficient in NMDA
receptors, they express sufficient levels to allow survival
to adulthood. Nr1 mutant mice display behavioral abnor-
malities that have been related to schizophrenia, and
these behaviors are ameliorated by the antipsychotic
drugs haloperidol and clozapine. The greater efficacy
of clozapine over haloperidol in the treatment of these
mice and the observation of unchanged levels of dopa-
minergic transmission suggest that the abnormal behav-
iors are produced without major modifications of the
dopaminergic system. These results provide evidence
supporting the hypothesis that dysfunction of gluta-
matergic pathways, specifically those utilizing NMDA
receptors, can lead to the pathologic changes that char-
acterize schizophrenia.
Results
Generation of a Hypomorphic Allele of Nr1
A mouse line expressing reduced levels of the NR1 sub-
unit of NMDA receptors was generated using homolo-
gous recombination in embryonic stem cells. A targeting
vector was designed that, upon integration into the Nr1
locus (now designated Grin1), resulted in the insertion
of a neomycin resistance gene into intron 20 (Figure 1).
ES cells carrying the targeted mutation were used to
generate mice with an altered Nr1 allele (Nr1neo 1/2).
These animals were intercrossed and used to examine
the impact of the intronic insertion on Nr1 expression
and on the survival of Nr1neo 2/2 mice. No perinatal
lethality was observed, and Nr1neo homozygous mice
were identified at expected frequency at weaning.
Nr1neo 2/2 mice were slightly smaller than littermates.
Although the weight difference between the two groups
persisted into adulthood, the magnitude of the differ-
Figure 1. Targeted Insertion of neo into Nr1 Intron 20 Results in
ence diminished, and the majority of Nr1neo 2/2 mice Decreases in Nr1 mRNA, Protein, and Functional NMDA Receptors
reached weights within the normal range. (A) Homologous recombination of the targeting plasmid with the
To examine the impact of the intronic insertion on endogenous Nr1 locus results in insertion of the neo gene into intron
Nr1 expression, RNA was prepared from whole brain 20 of Nr1 and the introduction of a new HindIII restriction site.
(B) An 11 kb HindIII fragment corresponding to the endogenous NR1extracts of wild-type, Nr1neo 1/2, and Nr1neo 2/2 mice
locus and a 9 kb HindIII fragment from the mutant allele can beand subjected to Northern blot analysis. Nr1 message
distinguished by Southern blot analysis of HindIII-digested DNA withlevels were reduced in the brains of Nr1neo 2/2 mice to
the probe indicated. (H, HindIII; E, EcoRI).
8.1% 6 1.3% of normal levels (Figure 1). Western blot (C) Northern (left panel) and Western (right panel) analysis of NR1
analysis indicated that NR1 protein levels were 7.3% 6 expression in total RNA and protein extracts prepared from brains
1.4% of that seen in wild-type mice (Figure 1). Novel of Nr1 1/1, Nr1neo 1/2, and Nr1neo 2/2 mice. Analysis of b-actin
expression verifies that the amount and integrity of the RNA loadedmRNA transcripts or proteins were not observed by
in each lane are similar. NR1 protein levels are quantified by WesternNorthern or Western blot analysis, indicating that the
analysis, and equivalent loading is demonstrated using antibodiesintronic insertion did not lead to the production of novel
specific for b-tubulin and with the nonspecific binding (NSB) at 23
splice variants from this allele. kDa seen using the antibody directed toward NR1.
The Nr1 mRNA produced in the brains of mutant mice (D) Radioligand binding of [3H]MK-801 to membrane homogenates
was cloned by RT±PCR and sequenced to verify that from the prefrontal cortex of Nr11/1 and Nr1neo 2/2 mice. A compe-
tition binding curve was generated using 2 nM [3H]MK-801 and in-alterations of the primary sequence were not introduced
creasing concentrations of MK-801 to calculate the IC50 and Bmax ofby the targeting construct or during the recombination
MK-801 binding. The IC50 for both the wild-type and mutant mice isevent. The sequence of Nr1 cDNA from the mutant mice
2 nM. The Bmax is 0.12 pmol/mg for the Nr1neo 2/2 and 1.2 pmol/mgdid not differ from published sequences for this gene. for wild-type mice (n 5 3 for each genotype).
Thus, the insertion of the neo gene into intronic Nr1
sequences resulted in a severe reduction in expression
of Nr1 without introducing point mutations or generating
NMDA Receptor±Deficient Mice
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Figure 2. Nr1neo 2/2 Animals Display In-
creases in Locomotion and Stereotypy Simi-
lar to Those Seen in Pharmacological Models
of Schizophrenia
(A) Locomotor activity and (B) stereotypy of
untreated Nr1neo 2/2 mice (open bars, open
triangles) and wild-type littermates (filled
bars, filled circles). Two-way ANOVA, p ,
0.0001, F 5 159.7. (C) Locomotor activity and
(D) stereotypy of untreated Nr1neo 2/2 mice
(open bars, open triangles) and wild-type lit-
termates treated with 3 mg/kg PCP, i.p. (filled
bars, filled circles). Two-way ANOVA analysis
of locomotor, p 5 0.0912. (E and F) Same as
above, except that wild-type mice are treated
with 0.2 mg/kg MK-801 i.p. Two-way ANOVA
of locomotor activity, p 5 0.9521. For (A)±(F),
*** 5 p , 0.0005, ** 5 p , 0.005, two-tailed
Student's t test. n 5 8 for all groups.
novel transcripts or proteins. This indicated that the Nr1neo 2/2 mice was reduced to that of wild-type mice
after 4 hr (data not shown).Nr1neo mutation produces a hypomorphic allele.
Expression of functional NMDA receptor in the pre- The increases in locomotion and stereotypy seen in
Nr1neo 2/2 mice were both qualitatively and quantita-frontal cortex of both wild-type and mutant animals was
determined by radioligand binding using the NMDA re- tively similar to that observed following administration
of the NMDA receptor antagonists PCP or MK-801 (Fig-ceptor antagonist, [3H]MK-801. Analysis of competition
binding curves generated with homogenates prepared ure 2). Wild-type mice injected with 3 mg/kg PCP or 0.2
mg/kg MK-801 demonstrated a pattern of motor activityfrom mutant and wild-type animals indicated that, as
expected, the IC50 for both animals was identical (Figure similar to untreated Nr1neo 2/2 mice, and no statistical
differences were found between the two groups.1). However, the calculated maximal binding of [3H]MK-
801 in the Nr1neo 2/2 was only 10% (0.12 pmol/mg) of
that of wild-type animals (1.2 pmol/mg). PCP and MK-801 Lack Effects in Nr1neo 2/2 Mice
Nr1neo 2/2 mice were also treated with PCP and MK-
801 to address the question of whether these drugsHyperlocomotion and Increased Stereotypic
Behaviors in Nr1neo 2/2 Mice elicit their motor stimulatory effects solely through their
interaction with NMDA receptors. PCP has been shownAnimal models of schizophrenia induced by treatment with
phencyclidine (PCP) or amphetamine display increases in to interact with other neurotransmitter systems, includ-
ing the dopaminergic and serotonergic systems (Akunneboth locomotion and stereotypic behaviors, and these
behaviors have been correlated with the positive symp- et al., 1992; Rothman, 1994), and it has been proposed
that these interactions are responsible for the motortoms of schizophrenia (Corbett et al., 1995; Moghaddam
and Adams, 1998). Motor activity was recorded over a stimulatory effects seen in rodents. If this were the
case, it would be expected that the administration of2±4 hr time period in a digital activity monitor. During
the first 2 hr of monitored activity, Nr1neo 2/2 mice be- PCP would lead to increases in motor activity beyond
what is seen in untreated Nr1neo 2/2 mice. However,haved with increased ambulation relative to wild-type con-
trols (3.93 greater, p 5 0.0001) and displayed increased Nr1neo 2/2 mice did not display increases in locomotion
or stereotypy when injected with doses of MK-801 orstereotypic movements (2.93 greater, p 5 0.005) (Figure
2). The increased motor activity occurred during habitua- PCP selected to elicit maximal motor stimulation (Glea-
son and Shannon, 1997) (Figure 3). Both drugs weretion to a new environment, since the motor activity of
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Figure 3. Lack of Motor Stimulatory Effects
of PCP and MK-801 in Nr1neo 2/2 Mice
(A) Locomotor activity and (B) stereotypy of
untreated Nr1neo 2/2 mice (open bars, open
triangles) and Nr1neo 2/2 mice treated with 3
mg/kg PCP, i.p. (filled bars, filled squares). (C
and D) Same as above, except that Nr1neo 2/2
mice are treated with 0.2 mg/kg MK-801, i.p.
(filled bars, filled squares). Two-way ANOVA
analysis of locomotor activity, p 5 0.4572. n 5
8 for all groups. p values calculated by a two-
tailed Student's t test are greater than 0.5
for all comparisons of horizontal activity and
stereotypic behavior.
ineffective as motor stimulants in Nr1neo 2/2 mice, sug- Nr1neo 2/2 mice was 0.08 mg/kg. Remarkably, this dose
was 403 lower than the ED50 of clozapine for suppres-gesting that at these doses their effects on behavior
were mediated solely through the direct suppression of sion of locomotion in wild-type mice (3.2 mg/kg). In con-
trast, the ED50 of haloperidol on the activity of Nr1neo 2/2NMDA receptors.
mice was 0.29 mg/kg, double the ED50 of 0.09 mg/kg for
wild-type activity.Attenuation of Abnormal Motor Behaviors
with Antipsychotics
The ªtypicalº antipsychotic drug haloperidol and the Dopamine Release and Metabolism Are Unchanged
ªatypicalº antipsychotic drug clozapine were tested in Nr1neo 2/2 Mice
for their ability to attenuate the hyperlocomotion and The neural pathways that mediate the increased motor
stereotypy of Nr1neo 2/2 mice. Haloperidol, a potent activity seen upon blockade of the NMDA receptor have
D2-dopamine receptor antagonist with relatively high
specificity (Hyttel, 1978), reduced these behaviors in
Nr1neo 2/2 animals to wild-type levels of activity (Figure
4). Although this result suggests that D2 dopaminergic
pathways are responsible for these behaviors, the same
dose of haloperidol also resulted in substantial impair-
ment of the locomotor activity of wild-type mice. This
effect of haloperidol on control mice is not surprising
given the therapeutic profile of this drug, which has
marked extrapyramidal side effects (EPS) at its effective
antipsychotic dose in humans (Hoffman and Donovan,
1995).
In contrast, clozapine and other atypical antipsychot-
ics can suppress psychotic symptoms without EPS (Ere-
shefsky et al., 1989; Gerlach, 1991). Clozapine's pharma-
cological profile includes antagonism at both D1- and
D2-like dopamine receptors and 5HT2 receptors and
also interactions with a1-adrenergic and H1 histamine
receptors (Ereshefsky et al., 1989; Gingrich and Caron,
1993). Clozapine was effective at attenuating the abnor-
Figure 4. Administration of Haloperidol and Clozapine Attenuatesmal motor behavior of Nr1neo 2/2 mice at a dose that
Abnormal Behaviors of Nr1neo 2/2 Micedid not affect the motor behavior of wild-type littermates
(A) Locomotor activity and (B) stereotypy of Nr1neo 2/2 mice (open(Figure 4).
bars) and their wild-type littermates (filled bars) following administra-The efficacies of clozapine and haloperidol were fur-
tion of either saline or 0.5 mg/kg haloperidol, i.p. (C and D) Same
ther studied by examining the ability of either drug to as above, except that mice were treated with either saline or 0.5
attenuate motor activity over a range of doses (Figure mg/kg clozapine, i.p. For (A)±(D), *** 5 p , 0.0005, ** 5 p , 0.005,
Student's two-tailed t test. n 5 8 for all groups.5). The ED50 of clozapine on the locomotor activity of
NMDA Receptor±Deficient Mice
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Figure 5. Clozapine Is More Effective Than Haloperidol in the Atten-
uation of Hyperlocomotion of Nr1neo 2/2 Mice Figure 6. Parameters of Striatal Dopamine Neurotransmission in
Nr1neo 2/2 and Wild-Type Mice(A) Dose dependence of haloperidol's effects on the motor activity
of wild-type (filled bars) and Nr1neo 2/2 mice (open bars), illustrated (A) Tissue content of dopamine (DA) and its metabolites (DOPAC,
as the percentage of control activity. Estimated ED50 of effect of HVA) in the striatum of Nr1neo 2/2 mice (filled bars, n 5 4) and wild-
haloperidol on the locomotor activity is 0.09 mg/kg (95% confidence type mice (open bars, n 5 4) measured by HPLC.
interval of 0.02±0.40) in wild-type mice and 0.29 mg/kg (95% confi- (B) Extracellular dopamine levels in the striatum of freely moving mice
dence interval of 0.14±0.61) in Nr1neo 2/2 mice. measured using quantitative ªlow perfusion rate microdialysis.º
(B) Animals were treated in a similar manner with clozapine. Esti- Wild-type mice (open bars, n 5 5), Nr1neo 2/2 mice (filled bars, n 5 4).
mated ED50 of effect of clozapine on the locomotor activity is 3.2
mg/kg (95% confidence interval of 0.35±30.5) in wild-type mice and
0.08 mg/kg (95% confidence interval of 0.01±0.37) in Nr1neo 2/2
that hyperlocomotion and stereotypy can be producedmice. For clozapine, two-way ANOVA analysis of dose response
reveals a significant genotype x drug response (p 5 0.0087). n 5 in the absence of increased dopaminergic tone.
6±8 for each dose.
Nr1neo 2/2 Mice Have Social Deficits that Can Be
Treated with Clozapinenot been established. Because hyperactivity is com-
Social withdrawal was apparent in adult Nr1neo 2/2 micemonly associated with increased dopaminergic tone, it
housed with wild-type littermates. Nr1neo 2/2 mice oftenhas been postulated that NMDA receptor antagonists
did not sleep piled in a nest with cagemates, remainingexert their effect by either directly or indirectly increas-
physically distant (Figure 7). The extent of this socialing dopaminergic tone (Imperato et al., 1990; Miller and
withdrawal was quantified using a resident±intruder be-Abercrombie, 1996). However, studies of dopamine re-
havioral assay, which can be used to measure ªap-lease and metabolism following pharmacological NMDA
proach-oriented behaviorº and social withdrawal (Cor-receptor antagonism have generated conflicting results,
bett et al., 1993; Dixon et al., 1994) (Figure 7). In thisand several groups have not observed alterations in
assay, a resident male mouse is housed alone for atdopamine transmission (Druhan et al., 1996; Pierce et
least a week and then a group-housed intruder male isal., 1997). To address this question, the extracellular
added to the resident cage. Typically, the resident maleconcentration of dopamine release was measured in the
actively initiates social investigation of the intruder,striatum of freely moving Nr1neo 2/2 and wild-type mice
rarely avoiding social interaction, and sometimes initiat-by quantitative in vivo microdialysis (Wang et al., 1997)
ing fights.(Figure 6). Levels of both dopamine and dopamine me-
The amount of time that wild-type or Nr1neo 2/2 resi-tabolites were unchanged in the striatum of Nr1neo 2/2
dents spent engaged in social investigation, socialmice in comparison to wild-type animals, indicating that
avoidance, or fighting behaviors was monitored over adopamine synthesis was unchanged. Similar results
6 min period (Figure 7). Nr1neo 2/2 residents displayedwere obtained by measuring the tissue content of dopa-
significant reductions in social investigation relative tomine and its metabolites from the striatum (Figure 6).
wild-type mice. Furthermore, Nr1neo 2/2 residents ex-To determine whether the failure to observe altered
hibited escape behaviors, actively avoiding interactiondopamine transmission in animals with increased motor
with intruder males. In contrast, wild-type residentsactivity is unique to Nr1neo 2/2 animals, microdialysis
rarely displayed escape behavior. Administration of clo-studies were carried out on wild-type and Nr1neo 2/2
zapine (0.5 mg/kg, i.p.) to Nr1neo 2/2 mice 1 hr prior toanimals following treatment with MK-801. This treatment
testing resulted in a general increase in social investiga-did not alter levels of striatal extracellular dopamine or
tion and a significant decrease in escape behavior (Fig-dopamine metabolites in wild-type or Nr1neo 2/2 mice
(data not shown). Taken together, these results suggest ure 7).
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Table 1. Clozapine Improves the Fertility of Nr1 neo2/2 Males
Mating Frequency Mating Frequency x2 Analysis
without Clozapine with Clozapine p Value
Nr1 neo1/1 84% (16/19) 100% (7/7) 0.5354
Nr1 neo2/2 0% (0/18) 30% (7/23) 0.0153
Mating frequency determined as the number of times that copulation
plugs were identified from superovulated females mated with the
individually housed male. Clozapine was administered at a dose of
0.5 mg/kg interperitoneally to males just prior to the addition of the
female. x2 analysis compares untreated and clozapine-treated males
for each genotype.
of Nr1neo 2/2 mice, clozapine (0.5 mg/kg) was adminis-
tered to males prior to mating. Following clozapine ad-
ministration, Nr1neo 2/2 males mated with ovulating fe-
males approximately 30% of the time, as evidenced by
the production of copulation plugs (Table 1). Successful
copulation was verified by examination of the females
for the presence of blastocyst stage embryos 3 days
after mating.
Discussion
We describe here the development of a mouse line that
expresses 5%±10% of normal levels of the NR1 subunit
of NMDA receptors. This level of expression is sufficient
to allow survival to adulthood. NMDA receptor±deficient
mice display an increase in both motor activity and ste-
reotypic behavior similar to that observed on treatment
of normal mice with the NMDA receptor antagonists
Figure 7. Nr1neo 2/2 Mice Display Social Withdrawal that Can Be PCP or MK-801 but are themselves resistant to the stim-
Quantified with the Resident±Intruder Behavioral Assay ulatory effects of these drugs. Treatment with either of
(A) Nr1neo 2/2 mice avoid contact with cagemates. Photographs of the antipsychotic drugs haloperidol or clozapine amelio-
three wild-type mice housed together (left panel) and four Nr1neo 2/2 rated the increased locomotion and stereotypy ob-
mice housed together (right panel) were taken every half-hour for 2
served in these mice. In addition to altered motor activ-hr. While wild-type mice typically prefer to nest, Nr1neo 2/2 mice
ity, NMDA receptor±deficient mice display deficits insleep isolated from other mice in the cage.
sexual and social behavior. These behavioral deficits(B) Time spent by the resident male over a 6 min period actively
pursuing social investigation of the intruder mouse, before and after can also be improved by treatment with clozapine.
treatment of Nr1neo 2/2 mice with clozapine (0.5 mg/kg. i.p.). The NR1-deficient mice studied here were maintained
(C) Time spent by the resident male over a 6 min period actively on a mixed genetic background consisting of alleles
avoiding social interaction (escape behavior), before and after treat-
derived from 129/Ola, C57BL/6, and DBA/2. The impor-ment of Nr1neo 2/2 mice with clozapine (0.5 mg/kg. i.p.).
tance of the genetic background on which mutations inFor (B) and (C), *** 5 p , 0.0005, ** 5 p , 0.005, Student's two-
specific genes are studied has been extensively de-tailed t test. Error bars demonstrate the standard error of the mean
(6 SEM), n 5 8 for all groups. scribed in recent reviews and commentaries (Branbury
Conference, 1997; Crawley et al., 1997). To increase the
probability that alleles of various genes, including those
linked to Nr1, were included in both populations, miceSexual Dysfunction of Nr1neo 2/2 Mice
Nr1neo 2/2 males housed with wild-type females failed that had inherited the wild-type 129 allele from the ES
chimeras were used in establishing the breeding popula-to produce litters even after extended breeding. Histo-
logical examination of the Nr1neo 2/2 testes revealed tion. However, while all Nr1neo 2/2 mice were expected
to be homozygous for 129 alleles of genes linked tothat all stages of spermatogenesis were represented
and that mature spermatozoa were present in the lumen Nr1, this would be true of only a quarter of the control
animals. We cannot, therefore, formally rule out the pos-of seminiferous tubules (data not shown). We studied
the frequency with which Nr1neo 2/2 mice copulate with sibility that homozygosity at these loci contributes in
part to the phenotype described. This seems unlikely,females by presenting Nr1neo 2/2 and wild-type males
with females induced to ovulate by treatment with hCG however, since previous studies have reported that 129
mice display slightly less motor activity than C57BL/6 and(Table 1). Successful mating was scored the following
morning by examination of the females for the presence DBA/2 (Kelly et al., 1998). Furthermore, strain-specific al-
leles were inherited equally in Nr1 1/1 and 2/2 mice,of a copulation plug. While the majority of wild-type
males produced copulation plugs, Nr1neo 2/2 males pro- based on the examination of 11 microsatellite marker
genes on ten chromosomes (data not shown).duced none. To determine whether this abnormal sexual
behavior was related to the observed social withdrawal The hypomorphic mutation introduced into the Nr1
NMDA Receptor±Deficient Mice
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gene allows sufficient expression to avoid perinatal le- resulting in an indirect increase in dopaminergic tone.
thality, thus allowing the consequences of chronic re- However, this hypothesis is not consistent with our fail-
duction in expression of all NMDA receptors to be stud- ure to detect significant changes in striatal dopaminer-
ied for the first time in adult animals. The genetic gic parameters. The results obtained from the Nr1 mu-
reduction of NMDA receptors results in a number of tant mice are more consistent with an alternate model
behaviors that have been traditionally characterized as proposed by Carlsson and colleagues (1997) in which
modeling behaviors associated with schizophrenia, and glutamatergic and dopaminergic neurons share com-
these behaviors are reversed with antipsychotic drugs. mon postsynaptic targets in the striatum with opposing
Increased motor activity and stereotypy are the defining effects. In this model, glutamate exerts an excitatory
features of current pharmacological models of schizo- influence on these target neurons, while dopamine ex-
phrenia (Carlsson and Carlsson, 1990; Corbett et al., erts an inhibitory influence (Carlsson et al., 1997). These
1995), and the amelioration of these behaviors is the target neurons in turn are proposed to have an inhibitory
standard screening test for the efficacy of antipsychotic action on the expression of motor behaviors. This model
drugs (Carlsson and Carlsson, 1990; Corbett et al., 1995; provides an explanation for our observation that hyper-
Moghaddam and Adams, 1998). Hyperlocomotion has locomotion in Nr1neo 2/2 mice does not result from in-
been correlated with the positive symptoms of schizo- creased dopaminergic tone.
phrenia, whereas social withdrawal, such as is observed We have demonstrated that while both typical and
in the Nr1neo 2/2 mice, has been correlated with negative atypical antipsychotics can attenuate hyperlocomotion
symptoms of the disease (Corbett et al., 1993; Dixon et and stereotypy in the Nr1neo 2/2 mice, clozapine is more
al., 1994). effective than haloperidol. Clozapine significantly im-
The infertility of Nr1neo 2/2 males may provide a model proved abnormal behavior at doses that had minimal
for another deficit observed in schizophrenia, as schizo- effects in wild-type mice, while haloperidol was effective
phrenic males have a significant reduction in fertility only at doses that also decreased the activity of wild-
(Odegard, 1980; Saugstad, 1989). This reduction has type animals. These results are in agreement with previ-
been attributed to a reduced ability to establish sexual ous pharmacological studies (Martin et al., 1998) and
relationships (Nimgaonkar et al., 1997) rather than to any are consistent with the interpretation that the increased
physiological abnormality. Our studies of the Nr1neo 2/2 motor activity of Nr1neo 2/2 mice is not due to increased
mice suggest that the observed infertility also results from dopaminergic tone. Clozapine, which also has a signifi-
changes in behavior, since it can be improved by treat- cant 5HT2A antagonist activity and interacts with H1
ment with clozapine. Clozapine has been reported to histamine and a-adrenergic receptors (Meltzer, 1991;
increase ªapproach-oriented behaviorº and reduce so- Martin et al., 1998), may be acting more directly on
cial withdrawal in mice (Dixon et al., 1994). This drug may pathways that are altered as a result of NR1 deficiency.
therefore restore fertility by allowing males to overcome Further characterization of Nr1neo 2/2 mice may estab-
their social indifference. In contrast to the infertility ob- lish which of clozapine's many targets are responsible
served in NMDA receptor±deficient mice, alterations in for attenuating the abnormal motor behaviors observed
sexual behavior have not been reported for pharmaco- in these mice.
logical models of schizophrenia. This difference may In summary, the mice described here support a model
reflect the difficulty in studying complex behaviors, such in which decreased NMDA receptor expression leads to
as mating, in models where behavior resembling schizo- extensive behavioral changes that are believed to model
phrenia is relatively short lived and underscores the po- schizophrenia. Furthermore, the evidence presented here
tential usefulness of a model in which chronic reduction suggests that monoaminergic transmission also plays
in NMDA receptor activity is achieved using a genetic a role in these changes. The response of Nr1neo 2/2
approach. mice to antipsychotics addresses the question of how
Schizophrenia is regarded as a progressive mental
symptoms of schizophrenia can be treated with drugs
illness because symptoms such as cognitive impairment
that act on dopaminergic and serotonergic systems, yet
worsen with age and early diagnosis and treatment have
be associated with a dysfunction of the glutamatergicbeen associated with an improved outcome (Coyle,
system. Continued studies of these mice will undoubt-1996). Future studies should allow us to determine
edly lead to a better understanding of the role of NMDAwhether the deficits in motor activity and social behavior
receptors in this disease. In addition, these animals willseen in the Nr1neo 2/2 also become more severe with
provide a tool for examining the involvement of NMDAage. In addition, as long-term administration of cloza-
receptors in the wide range of both normal and patholog-pine is required for optimal treatment of schizophrenia
ical processes in which they have been proposed to(Meltzer, 1991), it is possible that extended administra-
play a role.tion of clozapine will further improve the behavioral defi-
cits seen in the Nr1neo 2/2 mice.
Hyperlocomotion and stereotypy are commonly con- Experimental Procedures
sidered behaviors of increased dopaminergic tone
Generation of Nr1neo 2/2 Animals(Giros et al., 1996; Gainetdinov et al., 1999), and most
Genomic clones spanning the Nr1 locus were isolated from a 129/of the hypotheses concerning the motor stimulatory ef-
SvEv l bacteriophage library (Stratagene, La Jolla) using Nr1 cDNAfects of PCP or MK-801 suggest that these drugs either
exons 11±20 as a probe and used to generate the targeting con-
directly or indirectly increase dopaminergic tone (Impe- struct, Nr1neo. An 8.0 kb DNA fragment extending from the EcoRI
rato et al., 1990; Miller and Abercrombie, 1996). Such site of intron 10 to the SmaI site of intron 20 was inserted 59 of the
studies suggest that NMDA receptor blockade results in neo gene at the NotI site of the vector JNS2 (Dombrowicz et al.,
1993). A 2.5 kb SmaI-BamHI fragment corresponding to intron 20±the disinhibition of nigrostriatal dopaminergic neurons,
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intron 21 was cloned into the XbaI and BamHI sites of JNS2 with a first dissolved in a drop of glacial acetic acid. Pharmacological
agents were injected just prior to monitoring motor activity.NheI linker (New England Biolabs, Beverly, MA). Nr1neo was linearized
with PvuI, electroporated into E14Tg2a ES cells (Hooper et al., 1987),
and transformed cells selected in the presence of G418 and gan- Analysis of Motor Activity
ciclovir using methods previously described (Mohn and Koller, Nr1neo 2/2 animals and their wild-type littermates were obtained as
1995). Targeted clones were identified by Southern analysis and the F2 generation of Nr1neo 1/2 intercrosses. Animals were individu-
injected into blastocysts to generate chimeras, which were bred to ally tested for motor activity at 10±14 weeks of age under standard-
B6D2 animals to obtain Nr1neo 1/2 animals. These wild-type and ized environmental conditions using an automated Omnitech Digi-
heterozygous animals were intercrossed to obtain Nr1neo 1/2 off- scan apparatus (AccuScan Instruments, Columbus, OH), in a 42 cm2
spring mice, which were in turn mated to establish a breeding col- plexiglass chamber. Horizontal activity, measured as the total dis-
ony. All wild-type mice and mice homozygous for the mutant Nr1 tance traveled by each mouse, and stereotypy, measured as repeti-
gene were obtained from the intercross of these heterozygous an- tive movements with an interval less than 1 s, were recorded in 5
imals. min intervals over a 2 or 4 hr period, and the raw numbers were
averaged to give values for each 5 min interval (Gainetdinov et al.,
Northern Blot 1999). For all data presented in this paper, values represent means 6
Total RNA was prepared using RNAzol B (TelTest, Friendswood, SEM, and statistical significance was analyzed by two-way ANOVA
TX) from brains of 8-week-old mice. Twenty micrograms of total and by two-tailed Student's t test on 2 hr summed data. All experi-
RNA of each genotype was electrophoresed on a 1.2% agarose, ments were conducted in accordance with the NIH guidelines for
1.1% formaldehyde gel and transferred to nitrocellulose membrane. the care and use of animals and with approved animal protocols
The membrane was hybridized with the cDNA probe descibed above from the University of North Carolina at Chapel Hill Animal Care
and revealed by autoradiography. The membrane was stripped and and Use Committee and the Duke University Animal Care and Use
probed for mouse b-actin (Stratagene). NIH Image 1.62 Beta was Committee.
used to digitally capture and analyze autoradiograpic images from
the Northern blot. Assessment of Brain Dopamine Content
Tissue Content
Western Blot The striata from four adult wild-type or Nr1neo 2/2 mice were dis-
Protein extracts were prepared from brains of 8-week-old mice of sected and homogenized in 0.1 M HClO4 containing 100 ng/ml 3,4-
each genotype. Each brain was homogenized in a 5 ml buffer of 50 dihydroxybenzylamine (DHBA). Following centrifugation at 10,000 3
mM Tris-acetate (pH 7.4), 10% sucrose, 5 mM EDTA with 100 ml g for 10 min, the supernatants were filtered through 0.22 mm filters
protease inhibitor (Sigma, St. Louis). Homogenates were fraction- and analyzed for the levels of dopamine, DOPAC, and HVA by HPLC-
ated on a sucrose gradient to enrich for plasma membranes. Crude EC (Wang et al., 1997).
membrane fractions of 25 mg protein were electrophoresed in a Quantitative ªLow Perfusion Rateº Microdialysis
12%±20% gradient SDS-acrylamide gel, transferred to PVDF mem- Microdialysate samples were collected from the right striatum 24
brane, and incubated with a 1:1000 dilution of a-NMDAR1 mono- hr after surgery, separated, and quantified by HPLC as described
clonal antibody (clone 54.1, Pharmingen, San Diego, CA) for 1 hr at for freely moving mice (Wang et al., 1997). Mice were anesthetized
room temperature. Antibody binding was detected with ECL chemi- with chloral hydrate (400 mg/kg, i.p.), placed in a stereotaxic instru-
luminescence kit (Amersham, Arlington Heights, IL). PVDF mem- ment, and implanted with dialysis probes (2 mm membrane length,
branes were probed with an a-b tubulin monoclonal antibody 0.24 mm o.d.; Cuprophane, 6 kDa cut-off; CMA/Microdialysis, Solna,
(Sigma) to verify equivalent sample loading. Data representation Sweden) using CMA-11 guide cannulae into the right striatum (AP:
and densitometric analysis were done using NIH Image 1.62 Beta. 0.0, DV: 24.4, and L: 2.5 mm relative to bregma for both wild-type
and Nr1neo 2/2 mice) (Franklin and Paxinos, 1996). Following surgery
animals were returned to their cages and given free access to food[3H]MK-801 Binding
and water. Twenty-four hours after surgery, the dialysis probe wasPooled tissues from the prefrontal cortex of three wild-type and
connected to a syringe pump and perfused at 70 nl/min with artificialNr1neo 2/2 mice were homogenized in a binding buffer of 20 mM
CSF (Na1 150 mM; K1 3.0 mM; Ca21 1.4 mM; PO42 31.0 mM; Cl2HEPES, 1 mM EDTA (pH 7.0) with 100 mM glutamate, glycine, and
155 mM [pH 7.3]; with 0.25 mM ascorbate). After a 2 hr equilibrationspermidine as described in Nankai et al. (1996). Binding assays
period, perfusates were collected every 90 min in a tube containingincluded 80 mg membrane protein and 2 nM [3H]MK-801 in a volume
2 ml of 0.4 M HClO4. Levels of dopamine and metabolites wereof 150 ml. Tubes were incubated at 328C for 3 hr to reach equilibrium
quantified using an HPLC-EC as described in Wang et al., 1997.binding. Nonspecific binding was determined by 10 mM MK-801.
Bound ligand was separated from free by rapid filtration onto What-
man GF/B filters. Data were fit by nonlinear regression analysis Resident±Intruder Assay
using GraphPad Prism software. Male wild-type or Nr1neo 2/2 mice were housed individually or in
groups of three or four for at least 1 week prior to testing, and cage
bedding was changed 24 hr prior to testing. As described in DixonRT±PCR of Nr1neo 2/2 mRNA
et al. (1994), in this assay, a group-housed male (intruder) was placedTotal RNA from brains of Nr1neo 2/2 and wild-type mice was isolated
in the home cage of the individually housed male (resident), andas described above and 3 mg used as a template for reverse tran-
their behavior was video recorded for 6 min. Experimental groupsscription (cDNA Cycle Kit, Invitrogen, San Diego, CA), followed by
included eight wild-type residents, eight Nr1neo 2/2 residents, eightPCR amplification with primers specific for Nr1 exons 10±22. Over-
wild-type intruders, and eight Nr1neo 2/2 intruders. One week afterlapping regions of Nr1 cDNA were applified using three primer sets:
the initial set of experiments, the mice were retested under identical59ACAGAGAAGCCTCGAGGATA with 59AGGAAAACCACATGGCA
conditions, except that Nr1neo 2/2 mice were injected with 0.5 mg/GAG, 59TTCAGTCCCTTTGGCCGATT with 59GCGGGAGTCACATTC
kg (i.p.) clozapine 1 hr prior to testing. The videotaped behavior ofTTGAT, and 59GGGTACTCTTACCGAAGTAC with 59AGAAATACACA
the resident or intruder male was individually scored by two blindedGACAAGGCG. The PCR products were cloned into pCR2.1 using the
observers for time spent in social investigation (approaching, sniff-TA cloning kit (Invitrogen). For each PCR product, two independent
ing, grooming other mouse, and sexual behaviors), in escape behav-clones were sequenced by Taq cycle sequencing using an Applied
iors (actively avoiding other mouse), or in fighting behaviors. TheBioSystems 373 A Automated Sequencer (UNC-CH Automated Se-
scores for each behavior were subsequently averaged for each ge-quencing Facility).
notype.
Pharmacological Agents
Drugs were prepared fresh in saline and administered intraperitone- Assessment of Mating Behavior
Wild-type or Nr1neo 2/2 male mice aged 10±15 weeks were individu-ally in a volume of 0.1 ml/10 g body weight. MK-801 and PCP (Re-
search Biochemicals Inc., Natick, MA) were dissolved in saline, while ally housed and mated with a 3.5-week-old C57BL/6J female that
had been treated with pregnant mare serum and human chorionicclozapine (Reseach Biochemicals Inc.) and haloperidol (Sigma) were
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gonadotropin to induce ovulation (Masters and Wheeler, 1996). Mat- A.J., et al. (1997). Behavioral phenotypes of inbred mouse strains.
Psychopharmacology 132, 107±124.ings were initiated at 4:00 to 5:00 p.m., and the female mice were
examined for the presence of copulation plugs on the following Das, S., Sasaki, Y.F., Rothe, T., Prekumar, Y.F., Takasu, M., Crandall,
morning. A set of four wild-type males and six mutant males were J.E., Dikkes, P., Conner, D.A., Rayudu, P.V., Cheung, W., et al. (1998).
mated with ovulating females two to three times a week for 2 weeks. Increased NMDA current and spine density in mice lacking the
These males were subsequently used for a second group of matings NMDA receptor subunit NR3A. Nature 393, 377±381.
identical to the first in design except that 0.5 mg/kg clozapine was Dixon, A.K., Huber, C., and Lowe, D.A. (1994). Clozapine promotes
administered (i.p.) just prior to mating with females. Plug-positive approach-oriented behavior in male mice. J. Clin. Psychiatry 55
females (Rosenbauer et al., 1980) were checked 3 days later for the Suppl B, 4±7.
presence of blastocyst embryos in the uterine horns to verify that
Dombrowicz, D., Flamand, V., Brigman, K.K., Koller, B.H., and Kinet,the males had mated with the females and that they were fertile.
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